However, pretreatment with 10 g/g GHK-Cu significantly increased both SOD activity and GSH levels, bringing them to values comparable to control mice
Beyond weight reduction, semaglutide has shown cardiovascular benefits in cardiovascular outcome trials, supporting its role as a metabolic management tool rather than a weight-loss-only medication
Additionally, VA coverage depends on pharmacy availability at individual facilities, meaning approval at one facility doesn't guarantee access at another
Results vary from person to person, and most patients see progress within the first few weeks as dosage is safely adjusted
Read more from Omada Insights Lab here
Takeaway: The overwhelming majority of patients taking Ozempic or Wegovy will not experience this type of optic nerve damage